ANTI-PD-1 ANTIBODY
Clinical trials for ANTI-PD-1 ANTIBODY explained in plain language.
Never miss a new study
Get alerted when new ANTI-PD-1 ANTIBODY trials appear
Sign up with your email to follow new studies for ANTI-PD-1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to cure hepatitis b in over half of patients
Disease control Recruiting nowThis phase 2 trial tests a combination of an anti-PD-1 antibody, interferon, and standard antiviral drugs in 120 adults with chronic hepatitis B. The goal is to boost the immune system to clear the virus and achieve a functional cure, where the virus stays under control without l…
Matched conditions: ANTI-PD-1 ANTIBODY
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 16:45 UTC
-
New combo therapy aims to cure hepatitis b in over half of patients
Disease control Recruiting nowThis phase 2 trial tests a new combination of an anti-PD-1 antibody (a type of immunotherapy) plus standard antiviral drugs in 120 adults with chronic hepatitis B. The goal is to achieve a functional cure, where the virus is no longer active and patients can stop medication. The …
Matched conditions: ANTI-PD-1 ANTIBODY
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 26, 2026 15:29 UTC